These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 205137)

  • 1. Relationship of necrosis and tumor border to lymph node metastases and 10-year survival in carcinoma of the breast.
    Carter D; Pipkin RD; Shepard RH; Elkins RC; Abbey H
    Am J Surg Pathol; 1978 Mar; 2(1):39-46. PubMed ID: 205137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathological findings of breast cancer in patients surviving 25 years after radical mastectomy.
    Dawson PJ; Ferguson DJ; Karrison T
    Cancer; 1982 Nov; 50(10):2131-8. PubMed ID: 6290024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathologic correlates of prognosis in lymph node-positive breast carcinomas.
    Clayton F; Hopkins CL
    Cancer; 1993 Mar; 71(5):1780-90. PubMed ID: 8383579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and survival of female patients with nonpalpable breast carcinoma.
    Tinnemans JG; Wobbes T; Holland R; Hendriks JH; Van der Sluis RF; De Boer HH
    Ann Surg; 1989 Feb; 209(2):249-53. PubMed ID: 2537064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
    Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
    Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years.
    Rosen PP; Groshen S; Saigo PE; Kinne DW; Hellman S
    J Clin Oncol; 1989 Sep; 7(9):1239-51. PubMed ID: 2549203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of patients with carcinoma of breast without lymph node metastases in relation to the tumor types.
    Malinin TI; Lumb GD
    J Surg Oncol; 1977; 9(3):221-8. PubMed ID: 195141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for lymph node metastases in breast ductal carcinoma in situ with minimal invasive component.
    Wasserberg N; Morgenstern S; Schachter J; Fenig E; Lelcuk S; Gutman H
    Arch Surg; 2002 Nov; 137(11):1249-52. PubMed ID: 12413311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer.
    Noguchi M; Ohta N; Koyasaki N; Taniya T; Miyazaki I; Mizukami Y
    Cancer; 1991 Nov; 68(9):1918-25. PubMed ID: 1655229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer.
    Wong JH; Kopald KH; Morton DL
    Arch Surg; 1990 Oct; 125(10):1298-301; discussion 1301-2. PubMed ID: 2171453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic analysis of a large series of microinvasive breast cancers.
    Lillemoe TJ; Tsai ML; Swenson KK; Susnik B; Krueger J; Harris K; Rueth N; Grimm E; Leach JW
    Breast J; 2018 Jul; 24(4):574-579. PubMed ID: 29476574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathologic findings in nonpalpable invasive breast cancer.
    McKinney CD; Frierson HF; Fechner RE; Wilhelm MC; Edge SB
    Am J Surg Pathol; 1992 Jan; 16(1):33-6. PubMed ID: 1309412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis in stage II (T1N1M0) breast cancer.
    Rosen PP; Saigo PE; Braun DW; Weathers E; Kinne DW
    Ann Surg; 1981 Nov; 194(5):576-84. PubMed ID: 6271083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas. Mitotic count is the best single predictor.
    Clayton F
    Cancer; 1991 Sep; 68(6):1309-17. PubMed ID: 1651805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive ductal carcinoma of the breast with a predominant intraductal component: cooperative clinicopathologic study in seven Japanese centers.
    Enjoji M; Matsukuma A; Sakamoto G; Toyoshima S; Hirota T; Wada A; Ishida T; Enomoto K; Koyama H; Yamamoto H
    Jpn J Clin Oncol; 1992 Apr; 22(2):84-91. PubMed ID: 1320141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staging in the therapy of cancer of the breast.
    Silverberg SG
    Am J Clin Pathol; 1975 Dec; 64(6):756-63. PubMed ID: 173178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial mastectomy without radiation is adequate treatment for patients with stages 0 and I carcinoma of the breast.
    Hermann RE; Esselstyn CB; Grundfest-Broniatowski S; Steiger E; Vogt DP; Broughan TA; Dowden RV; Hardesty I; Medendorp SV; Boyett JM
    Surg Gynecol Obstet; 1993 Sep; 177(3):247-53. PubMed ID: 8395083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angioinvasion in breast carcinoma. An immunohistochemical study of factor VIII-related antigen.
    Martin SA; Perez-Reyes N; Mendelsohn G
    Cancer; 1987 Jun; 59(11):1918-22. PubMed ID: 3032395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some international differences in histology and survival in breast cancer.
    Morrison AS; Black MM; Lowe CR; MacMahon B; Yuasa S
    Int J Cancer; 1973 Mar; 11(2):261-7. PubMed ID: 4364258
    [No Abstract]   [Full Text] [Related]  

  • 20. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.
    Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.